Works about OVARIAN cancer treatment
Results: 1414
Platinum-Based Neoadjuvant Chemotherapy versus Primary Surgery in Ovarian Carcinoma International Federation of Gynecology and Obstetrics Stages IIIc and IV: A Systematic Review and Meta-Analysis.
- Published in:
- Gynecologic & Obstetric Investigation, 2018, v. 83, n. 3, p. 209, doi. 10.1159/000485618
- By:
- Publication type:
- Article
Stromal Growth Differentiation Factor 15 and Its Association with Ovarian Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Association of Vasculogenic Mimicry Formation and CD133 Expression with Poor Prognosis in Ovarian Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Use of TachoSil® to Prevent Symptomatic Lymphocele after an Aggressive Tumor Debulking with Lymphadenectomy for Advanced Stage Ovarian Cancer. A Pilot Study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Clinical Outcomes among Women with Mucinous Adenocarcinoma of the Ovary.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A Giant Ovarian Tumor Causing Anasarca and Dyspnea Successfully Managed after Preoperative Drainage.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Fertility-Sparing Surgery for Young Women with Early-Stage Epithelial Ovarian Cancer.
- Published in:
- Gynecologic & Obstetric Investigation, 2013, v. 76, n. 1, p. 14, doi. 10.1159/000350797
- By:
- Publication type:
- Article
Robotic Radical Parametrectomy in Cervical Cancer.
- Published in:
- Gynecologic & Obstetric Investigation, 2011, v. 72, n. 3, p. 179, doi. 10.1159/000324499
- By:
- Publication type:
- Article
Optimal Debulking Surgery Followed by Paclitaxel/Platinum Chemotherapy Is Very Effective in Treating Ovarian Carcinosarcomas: A Single Center Experience.
- Published in:
- Gynecologic & Obstetric Investigation, 2011, v. 72, n. 3, p. 208, doi. 10.1159/000323775
- By:
- Publication type:
- Article
Human umbilical blood mononuclear cell-derived mesenchymal stem cells serve as interleukin-21 gene delivery vehicles for epithelial ovarian cancer therapy in nude mice.
- Published in:
- Biotechnology & Applied Biochemistry, 2011, v. 58, n. 6, p. 397, doi. 10.1002/bab.63
- By:
- Publication type:
- Article
Hutchinson's sign.
- Published in:
- Portuguese Journal of Dermatology & Venereology, 2023, v. 81, n. 2, p. 145, doi. 10.24875/PJDV.23000019
- By:
- Publication type:
- Article
Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00297-5
- By:
- Publication type:
- Article
Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00297-5
- By:
- Publication type:
- Article
MicroRNA Regulation of RAD51 in Serous Ovarian Cancer and Chemotherapy Response.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Augmentation of Response to Chemotherapy by microRNA-506 Through Regulation of RAD51 in Serous Ovarian Cancers.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 7, p. 1, doi. 10.1093/jnci/djv108
- By:
- Publication type:
- Article
Cediranib Aims for a Comeback.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 3, p. 6, doi. 10.1093/jnci/djv068
- By:
- Publication type:
- Article
Analysis of Serial Ovarian Volume Measurements and Incidence of Ovarian Cancer: Implications for Pathogenesis.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 10, p. 1, doi. 10.1093/jnci/dju262
- By:
- Publication type:
- Article
Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 10, p. 1, doi. 10.1093/jnci/dju249
- By:
- Publication type:
- Article
Recommended Patient-Reported Core Set of Symptoms and Quality-of-Life Domains to Measure in Ovarian Cancer Treatment Trials.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 7, p. 1, doi. 10.1093/jnci/dju128
- By:
- Publication type:
- Article
Prescription Use of Paracetamol and Risk for Ovarian Cancer in Denmark.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 6, p. 1, doi. 10.1093/jnci/dju111
- By:
- Publication type:
- Article
Individualizing Care for Ovarian Cancer Patients Using Big Data.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Downfall of Iniparib: A PARP Inhibitor That Doesn't Inhibit PARP After All.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 1, p. 1, doi. 10.1093/jnci/djt447
- By:
- Publication type:
- Article
PARP Inhibitors:Targeting the Right Patients.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 24, p. 1851, doi. 10.1093/jnci/djs514
- By:
- Publication type:
- Article
DNA Repair Pathway Score for Predicting Chemotherapy Response in Ovarian Cancer Patients.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 9, p. NP, doi. 10.1093/jnci/djs234
- Publication type:
- Article
Targeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer Treatment.
- Published in:
- Biomolecules (2218-273X), 2016, v. 6, n. 1, p. 3, doi. 10.3390/biom6010003
- By:
- Publication type:
- Article
An Unusual Case of Ovarian Carcinomatosis with Microscopic Tumor Embolism Leading to Rectal Ischemia and Perforation.
- Published in:
- Clinical Endoscopy, 2018, v. 51, n. 3, p. 294, doi. 10.5946/ce.2017.152
- By:
- Publication type:
- Article
Sonographers' self-reported visualization of normal postmenopausal ovaries on transvaginal ultrasound is not reliable: results of expert review of archived images from UKCTOCS.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Abstracts of the 26th World Congress on Ultrasound in Obstetrics and Gynecology, Rome, Italy, 24-28 September 2016.
- Published in:
- 2016
- By:
- Publication type:
- journal article
P12.08: Girads ovarian tumour classification: a meta-analysis.
- Published in:
- Ultrasound in Obstetrics & Gynecology, 2016, v. 48, p. 203, doi. 10.1002/uog.16609
- By:
- Publication type:
- Article
OC06.02: Subjective ultrasound assessment and ultrasound-guided tru-cut biopsy to differentiate primary ovarian cancer from metastatic non-ovarian cancer.
- Published in:
- Ultrasound in Obstetrics & Gynecology, 2014, v. 44, p. 13, doi. 10.1002/uog.13497
- By:
- Publication type:
- Article
Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis ( IOTA) studies.
- Published in:
- Ultrasound in Obstetrics & Gynecology, 2013, v. 41, n. 1, p. 9, doi. 10.1002/uog.12323
- By:
- Publication type:
- Article
Ultrasonographic appearance of metastatic non-gynecological pelvic tumors.
- Published in:
- Ultrasound in Obstetrics & Gynecology, 2012, v. 39, n. 2, p. 215, doi. 10.1002/uog.10068
- By:
- Publication type:
- Article
Observational Studies on the Association Between Post-diagnostic Metformin Use and Survival in Ovarian Cancer: A Systematic Review and Meta-Analysis.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00458
- By:
- Publication type:
- Article
Macrophage Polarization in the Development and Progression of Ovarian Cancers: An Overview.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00421
- By:
- Publication type:
- Article
Nanoformulation of Talazoparib Delays Tumor Progression and Ascites Formation in a Late Stage Cancer Model.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00353
- By:
- Publication type:
- Article
Inhibition of CDC25B With WG-391D Impedes the Tumorigenesis of Ovarian Cancer.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00236
- By:
- Publication type:
- Article
Radiopharmaceuticals for Relapsed or Refractory Ovarian Cancers.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00180
- By:
- Publication type:
- Article
Immunotherapies based on PD‐1/PD‐L1 pathway inhibitors in ovarian cancer treatment.
- Published in:
- Clinical & Experimental Immunology, 2019, v. 195, n. 3, p. 334, doi. 10.1111/cei.13255
- By:
- Publication type:
- Article
Pure Primary Ovarian Squamous Cell Carcinoma Perforating the Rectum.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Ruptured Ectopic Pregnancy with Contralateral Ovarian Serous Cyst Adenoma Torsion: Laparoscopic Management of Double Trouble.
- Published in:
- Case Reports in Obstetrics & Gynecology, 2016, p. 1, doi. 10.1155/2016/2980941
- By:
- Publication type:
- Article
Sister Mary Joseph Nodule as a First Manifestation of a Metastatic Ovarian Cancer.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Recurrent Pseudomembranous Colitis in an Ovarian Cancer Patient Undergoing Carboplatin Chemotherapy.
- Published in:
- Case Reports in Obstetrics & Gynecology, 2016, p. 1, doi. 10.1155/2016/7540302
- By:
- Publication type:
- Article
A Case of Spontaneous Tumor Lysis Syndrome in a Patient with Ovarian Cancer.
- Published in:
- Case Reports in Obstetrics & Gynecology, 2015, v. 2015, p. 1, doi. 10.1155/2015/461870
- By:
- Publication type:
- Article
Microenvironment-induced downregulation of miR-193b drives ovarian cancer metastasis.
- Published in:
- Oncogene, 2015, v. 34, n. 48, p. 5923, doi. 10.1038/onc.2015.43
- By:
- Publication type:
- Article
Response to 'Comment on "Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States"'.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Comment on "Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States".
- Published in:
- 2019
- By:
- Publication type:
- Letter
Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cost Effectiveness of Chemotherapeutic Agents and Targeted Biologics in Ovarian Cancer: A Systematic Review.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Immunoreactive Microenvironment Modulator GBP5 Suppresses Ovarian Cancer Progression by Inducing Canonical Pyroptosis.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 11, p. 3510, doi. 10.7150/jca.94616
- By:
- Publication type:
- Article
Single-cell and spatial transcriptome sequencing uncover a platinum-resistant cluster overexpressed TACSTD2 in high-grade serous ovarian cancer.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 11, p. 3427, doi. 10.7150/jca.95269
- By:
- Publication type:
- Article